Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1992-10-26
|
pubmed:abstractText |
We examined the anti-ulcer effects of FRG-8813, a new-type histamine H2-receptor antagonist, in chronic ulcer models of rats and mice (W/WV). FRG-8813, given orally twice a day for 7 days, accelerated the healing of gastric or duodenal ulcer induced by acetic acid injection or application at the non-antisecretory doses (0.3 approximately 3 mg/kg). Administration of FRG-8813 to rats with ulcers increased the amounts of mucus in the gastric mucosa. These actions of FRG-8813 were more potent than those of famotidine or cimetidine. In W/WV mice, several ulcers spontaneously developed on gastric mucosa during the 8 weeks after the birth. The ulcers were aggravated by several unknown factors after the ulcer generation in W/WV mice. The aggravation of ulcers was inhibited by the 4-week administration of FRG-8813 with diet at the dose of 1 or 10 mg/kg/day, but was not inhibited by cimetidine at the dose of 100 mg/kg/day. From these results, we suggest that FRG-8813 is able to accelerate the healing of ulcers by antisecretory plus increasing actions on the integrity of the gastric mucosal defense mechanisms; therefore FRG-8813 is expected to be a useful drug for the treatment of gastric or duodenal ulcers in humans.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetamides,
http://linkedlifedata.com/resource/pubmed/chemical/Histamine H2 Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Piperidines,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridines,
http://linkedlifedata.com/resource/pubmed/chemical/lafutidine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0015-5691
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
99
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
411-20
|
pubmed:dateRevised |
2011-7-27
|
pubmed:meshHeading |
pubmed-meshheading:1356898-Acetamides,
pubmed-meshheading:1356898-Animals,
pubmed-meshheading:1356898-Chronic Disease,
pubmed-meshheading:1356898-Disease Models, Animal,
pubmed-meshheading:1356898-Duodenal Ulcer,
pubmed-meshheading:1356898-Gastric Acid,
pubmed-meshheading:1356898-Histamine H2 Antagonists,
pubmed-meshheading:1356898-Male,
pubmed-meshheading:1356898-Mice,
pubmed-meshheading:1356898-Piperidines,
pubmed-meshheading:1356898-Pyridines,
pubmed-meshheading:1356898-Rats,
pubmed-meshheading:1356898-Rats, Wistar,
pubmed-meshheading:1356898-Stomach Ulcer
|
pubmed:year |
1992
|
pubmed:articleTitle |
[Effects of FRG-8813, a new-type histamine H2-receptor antagonist, on the healing of gastric and duodenal ulcer in rats and spontaneously ulcerative mice].
|
pubmed:affiliation |
Pharmaceuticals Research Laboratories, Fujirebio, Inc., Tokyo, Japan.
|
pubmed:publicationType |
Journal Article,
English Abstract
|